Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21392

1.

Acute pulmonary embolism caused by enlarged uterine leiomyoma: A rare presentation.

Khademvatani K, Rezaei Y, Kerachian A, Seyyed-Mohammadzad MH, Eskandari R, Rostamzadeh A.

Am J Case Rep. 2014 Jul 13;15:300-3. doi: 10.12659/AJCR.890607. eCollection 2014.

PMID:
25061497
[PubMed - in process]
2.

Genotype-guided Drug Prescribing: A Systematic Review and Meta-analysis of Randomized Control Trials.

Goulding R, Dawes D, Price M, Wilkie S, Dawes M.

Br J Clin Pharmacol. 2014 Jul 24. doi: 10.1111/bcp.12475. [Epub ahead of print]

PMID:
25060532
[PubMed - as supplied by publisher]
3.

Construction and Radiolabeling of Adenovirus Variants that Incorporate Human Metallothionein into Protein IX for Analysis of Biodistribution.

Liu L, Rogers BE, Aladyshkina N, Cheng B, Lokitz SJ, Curiel DT, Mathis JM.

Mol Imaging. 2014 Jul 1;13(0):1-12.

PMID:
25060486
[PubMed - in process]
4.

Traumatic intracranial hemorrhage in patients using warfarin or clopidogrel.

Alsakha A, Guttman A.

CJEM. 2014 Jul 1;16(4):327-9.

PMID:
25060088
[PubMed - in process]
5.

Influence of chronic kidney disease on warfarin therapy for atrial fibrillation-reply.

Carrero JJ, Szummer K, Jernberg T.

JAMA. 2014 Jun 25;311(24):2542-3. doi: 10.1001/jama.2014.5587. No abstract available.

PMID:
25058091
[PubMed - in process]
6.

Influence of chronic kidney disease on warfarin therapy for atrial fibrillation.

Shah R, Roberts KM, Ramanathan KB.

JAMA. 2014 Jun 25;311(24):2542. doi: 10.1001/jama.2014.5581. No abstract available.

PMID:
25058090
[PubMed - in process]
7.

Influence of chronic kidney disease on warfarin therapy for atrial fibrillation.

Vaduganathan M, Greene SJ.

JAMA. 2014 Jun 25;311(24):2541-2. doi: 10.1001/jama.2014.5576. No abstract available.

PMID:
25058089
[PubMed - in process]
8.

Left Atrial Appendage Occlusion With the WATCHMANâ„¢ for Stroke Prevention in Atrial Fibrillation.

Price MJ.

Rev Cardiovasc Med. 2014;15(2):142-51.

PMID:
25051131
[PubMed - in process]
9.

Effect of age and sex on warfarin dosing.

Khoury G, Sheikh-Taha M.

Clin Pharmacol. 2014 Jul 12;6:103-6. doi: 10.2147/CPAA.S66776. eCollection 2014.

PMID:
25050078
[PubMed]
Free PMC Article
10.

Safety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation.

Uhm JS, Won H, Joung B, Nam GB, Choi KJ, Lee MH, Kim YH, Pak HN.

Yonsei Med J. 2014 Sep 1;55(5):1238-45. doi: 10.3349/ymj.2014.55.5.1238.

PMID:
25048480
[PubMed - in process]
Free Article
11.

Antithrombotics in atrial fibrillation and coronary disease.

Velagapudi P, Turagam MK, Agrawal H, Mittal M, Kocheril AG, Aggarwal K.

Expert Rev Cardiovasc Ther. 2014 Aug;12(8):977-86. doi: 10.1586/14779072.2014.937427.

PMID:
25046150
[PubMed - in process]
12.

Evaluation of risk factors in patients with vitamin K-dependent coagulopathy presumed to be caused by exposure to brodifacoum.

Lee HJ, You MR, Moon WR, Sul H, Chung CH, Park CY, Park SG.

Korean J Intern Med. 2014 Jul;29(4):498-508. doi: 10.3904/kjim.2014.29.4.498. Epub 2014 Jun 27.

PMID:
25045298
[PubMed - in process]
Free PMC Article
13.

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology.

Hallgreen CE, van den Ham HA, Mt-Isa S, Ashworth S, Hermann R, Hobbiger S, Luciani D, Micaleff A, Thomson A, Wang N, van Staa TP, Downey G, Hirsch I, Hockley K, Juhaeri J, Metcalf M, Mwangi J, Nixon R, Peters R, Stoeckert I, Waddingham E, Tzoulaki I, Ashby D, Wise L.

Pharmacoepidemiol Drug Saf. 2014 Jul 5. doi: 10.1002/pds.3676. [Epub ahead of print]

PMID:
25043919
[PubMed - as supplied by publisher]
14.

Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia.

Chang CK, Scali ST, Feezor RJ, Beck AW, Waterman AL, Huber TS, Berceli SA.

J Vasc Surg. 2014 Jul 16. pii: S0741-5214(14)01120-3. doi: 10.1016/j.jvs.2014.06.009. [Epub ahead of print]

PMID:
25043889
[PubMed - as supplied by publisher]
15.

New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome.

Win K, Rodgers GM.

Am J Hematol. 2014 Jul 5. doi: 10.1002/ajh.23797. [Epub ahead of print] No abstract available.

PMID:
25043836
[PubMed - as supplied by publisher]
16.

[Establishment and preliminary validation of warfarin maintenance dose algorithm in Chinese Han Population].

Lou Y, Hua L, Han L, Li Y, Zhang X, Tang M, Yu H, Liu Z, Wang W, Xu J, Liu H, Li Y.

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 May;42(5):384-8. Chinese.

PMID:
25042915
[PubMed - in process]
17.

Genetic determinants of acenocoumarol and warfarin maintenance dose requirements in Slavic population: A potential role of CYP4F2 and GGCX polymorphisms.

Wypasek E, Branicka A, Awsiuk M, Sadowski J, Undas A.

Thromb Res. 2014 Jul 7. pii: S0049-3848(14)00348-X. doi: 10.1016/j.thromres.2014.06.022. [Epub ahead of print]

PMID:
25042728
[PubMed - as supplied by publisher]
18.

[Cerebral amyloid angiopathy.]

Makotrova TA, Levin OS, ArablinskiÄ­ AV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(6 Vypusk 2 Nevrologiia i psikhiatriia pozhilogo vozrasta):87-93. Russian.

PMID:
25042509
[PubMed - as supplied by publisher]
19.

Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis.

Franchini M, Mengoli C, Cruciani M, Bonfanti C, Mannucci PM.

J Thromb Haemost. 2014 Jul 8. doi: 10.1111/jth.12647. [Epub ahead of print]

PMID:
25040440
[PubMed - as supplied by publisher]
20.

Prothrombin Complex Concentrate (PCC) for Non-Vitamin K Oral Anticoagulant (NOAC) reversal: Good enough for now?

Makris M.

J Thromb Haemost. 2014 Jul 14. doi: 10.1111/jth.12667. [Epub ahead of print]

PMID:
25039898
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk